These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23108355)

  • 1. The changing epidemiology of meningococcal disease in North America 1945-2010.
    Baccarini C; Ternouth A; Wieffer H; Vyse A
    Hum Vaccin Immunother; 2013 Jan; 9(1):162-71. PubMed ID: 23108355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal disease and vaccination in North America.
    Pollard AJ; Scheifele D
    J Paediatr Child Health; 2001 Oct; 37(5):S20-7. PubMed ID: 11885732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic two-strain dynamic model.
    Vickers DM; Anonychuk AM; De Wals P; Demarteau N; Bauch CT
    Vaccine; 2015 Jan; 33(1):268-75. PubMed ID: 24103896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of invasive meningococcal disease in Cyprus 2004 to 2018.
    Koliou M; Kasapi D; Mazeri S; Maikanti P; Demetriou A; Skordi C; Agathocleous M; Tzanakaki G; Constantinou E
    Euro Surveill; 2020 Jul; 25(30):. PubMed ID: 32734853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.
    Taha MK; Presa J; Serra L
    Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].
    Křížová P; Vacková Z; Musílek M; Kozáková J
    Epidemiol Mikrobiol Imunol; 2013 Dec; 62(4):138-47. PubMed ID: 24467175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature.
    Guedes S; Bertrand-Gerentes I; Evans K; Coste F; Oster P
    BMC Public Health; 2022 Feb; 22(1):380. PubMed ID: 35197024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines.
    Stein-Zamir C; Shoob H; Abramson N; Block C; Keller N; Jaffe J; Valinsky L
    Hum Vaccin Immunother; 2019; 15(1):242-248. PubMed ID: 30156954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing and dynamic epidemiology of meningococcal disease.
    Halperin SA; Bettinger JA; Greenwood B; Harrison LH; Jelfs J; Ladhani SN; McIntyre P; Ramsay ME; Sáfadi MA
    Vaccine; 2012 May; 30 Suppl 2():B26-36. PubMed ID: 22178525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Epidemiology and Trends in Meningococcal Disease-United States, 1996-2015.
    MacNeil JR; Blain AE; Wang X; Cohn AC
    Clin Infect Dis; 2018 Apr; 66(8):1276-1281. PubMed ID: 29126310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for vaccine prevention of meningococcal infection.
    Harrison LH
    Clin Microbiol Rev; 2006 Jan; 19(1):142-64. PubMed ID: 16418528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of the meningococcal serogroup C conjugate vaccine in Canada between 2002 and 2012.
    Sadarangani M; Scheifele DW; Halperin SA; Vaudry W; Le Saux N; Tsang R; Bettinger JA;
    Clin Infect Dis; 2014 Nov; 59(9):1208-15. PubMed ID: 25069868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia.
    Marshall HS; Lally N; Flood L; Phillips P
    Med J Aust; 2020 Feb; 212(2):89-93. PubMed ID: 31909501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological and Molecular Characterization of Invasive Meningococcal Disease in Italy, 2008/09-2012/13.
    Neri A; Pezzotti P; Fazio C; Vacca P; D'Ancona FP; Caporali MG; Stefanelli P
    PLoS One; 2015; 10(10):e0139376. PubMed ID: 26445461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological burden of meningococcal disease in Brazil: A systematic literature review and database analysis.
    Presa JV; de Almeida RS; Spinardi JR; Cane A
    Int J Infect Dis; 2019 Mar; 80():137-146. PubMed ID: 30641200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.
    Atkinson B; Gandhi A; Balmer P
    Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive meningococcal disease in South-Eastern European countries: Do we need to revise vaccination strategies?
    Tzanakaki G; Cabrnochová H; Delić S; Draganescu A; Hilfanova A; Onozó B; Pokorn M; Skoczyńska A; Tešović G
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301186. PubMed ID: 38173392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
    Wormsbecker AE; Wong K; Jamieson FB; Crowcroft NS; Deeks SL
    Vaccine; 2015 Oct; 33(42):5678-5683. PubMed ID: 26299749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.